Mti unveils strategy to boost corporate value and stock price

Mti Ltd. announced on October 17, 2025, a new strategy to enhance corporate value by focusing on the cost of capital and stock price. The initiative aims to improve both Return on Equity (ROE) and Price-to-Earnings Ratio (PER), thereby boosting the Price-to-Book Ratio (PBR). For FY2024, Mti’s ROE reached 16.1%, surpassing its 8.1% cost of equity, indicating a strong foundation for sustained profit growth. PBR for FY2024 stood at 3.9 times, while PER was 29.6 times, reflecting an upward trend in market valuation due to increased market capitalization.

The strategy encompasses several key initiatives, including expanding core business revenue through organic growth in healthcare, pharmacy DX, childcare DX, and school DX. Mti plans to optimize its business portfolio by focusing resources on core businesses and divesting unprofitable segments. Financially, the company will balance investment with shareholder returns through M&A and a gradual increase in dividend payout ratio, alongside disciplined use of financial leverage to optimize external funding across the group.

To improve its PER, Mti will disclose medium- to long-term management targets and articulate growth stories for its core businesses. The company also aims to reduce its cost of equity capital by strengthening engagement with the stock market through enhanced IR activities and reducing performance volatility via improved budget management. Mti commits to robust dialogue with shareholders and investors, including hybrid annual general meetings, post-AGM reporting sessions, regular individual investor meetings, and quarterly financial results briefings.